conference paper
Reprogramming immunosuppressive tumor-associated macrophages potentiates standard-of-care therapy in melanoma
December 1, 2022
Cancer Immunology Research
Reprogramming immunosuppressive tumor-associated macrophages potentiates standard-of-care therapy in melanoma